AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia
Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medic...
30 Apr 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of ...
31 Mar 2009
Managing cardiotoxicity while treating cancer
Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute of...
18 Mar 2009
Azacitidine for Myelodysplastic Syndrome
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
19 Feb 2009
Effects of Myelodysplastic Syndrome
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
19 Feb 2009
How azacitidine works
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
19 Feb 2009
Myelodysplastic Syndromes and Acute Myeloid Leukaemia
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
19 Feb 2009
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
ECCO-ESMO Roundtable discussion - Full Version
16 Feb 2009
Clinical Requirements Regarding In Silico Oncology
Professor Norbert Graf, Director of Oncology and Haematology Clinic, University ...
23 Jan 2009
Breast Cancer Cell Apoptosis
Dr Anthony Letai, Assistant Professor of Medicine, Haematologic Malignancies, Da...
9 Jan 2009
Haematologist, Baltimore, USA
Dr. Michael Auerbach
3 Dec 2008
